Andrew Zloza, MD, PhD

Andrew Zloza, MD, PhD

Rush University

H-index: 32

North America-United States

About Andrew Zloza, MD, PhD

Andrew Zloza, MD, PhD, With an exceptional h-index of 32 and a recent h-index of 27 (since 2020), a distinguished researcher at Rush University, specializes in the field of Cancer, Viral Infection, Immunology, Autoimmunity.

His recent articles reflect a diverse array of research interests and contributions to the field:

Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment

PIGMENT CELL & MELANOMA Research

Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous …

Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer

Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses

A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study

NKG2D signaling shifts the balance of CD8 T cells from single cytokine-to polycytokine-producing effector cells

Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ

Andrew Zloza, MD, PhD Information

University

Position

___

Citations(all)

4651

Citations(since 2020)

3257

Cited By

2714

hIndex(all)

32

hIndex(since 2020)

27

i10Index(all)

55

i10Index(since 2020)

47

Email

University Profile Page

Rush University

Google Scholar

View Google Scholar Profile

Andrew Zloza, MD, PhD Skills & Research Interests

Cancer

Viral Infection

Immunology

Autoimmunity

Top articles of Andrew Zloza, MD, PhD

Title

Journal

Author(s)

Publication Date

Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment

Frontiers in Oncology

Kajal H Gupta

Eileena F Giurini

Andrew Zloza

2024/2/27

PIGMENT CELL & MELANOMA Research

Pigment Cell Melanoma Res

Adi Nagler

David W Vredevoogd

Michal Alon

Phil F Cheng

Sophie Trabish

...

2020

Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous …

JID Innovations

Kevinn Eddy

Kajal Gupta

Mohamad Naser Eddin

Christina Marinaro

Sanjana Putta

...

2024/3/1

Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer

Journal for immunotherapy of cancer

Sachin R Jhawar

Shang-Jui Wang

Aditya Thandoni

Praveen K Bommareddy

Jenna H Newman

...

2023

Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses

Journal of Translational Medicine

Josef W Goldufsky

Preston Daniels

Michael D Williams

Kajal Gupta

Bruce Lyday

...

2023/7/19

A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study

Cancer Immunology, Immunotherapy

Ann W Silk

Steven J O’Day

Howard L Kaufman

Jennifer Bryan

Jacqueline T Norrell

...

2023/6

NKG2D signaling shifts the balance of CD8 T cells from single cytokine-to polycytokine-producing effector cells

Molecular Immunology

Frederick J Kohlhapp

Jeremy A O’Sullivan

Tamson V Moore

Andrew Zloza

José A Guevara-Patiño

2023/3/1

Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ

International Journal of Molecular Sciences

Jeremy A O’Sullivan

Frederick J Kohlhapp

Andrew Zloza

Lourdes Plaza-Rojas

Brianna Burke

...

2023/1

Intratumoral Influenza Vaccine Administration Attenuates Breast Cancer Growth and Restructures the Tumor Microenvironment through Sialic Acid Binding of Vaccine Hemagglutinin

International journal of molecular sciences

Preston Daniels

Stefanie Cassoday

Kajal Gupta

Eileena Giurini

Malia E Leifheit

...

2023/12/22

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma

Frontiers in Oncology

Ann W Silk

Brendan Curti

Jennifer Bryan

Tracie Saunders

Weichung Shih

...

2023/2/9

A spontaneous melanoma mouse model applicable for a longitudinal chemotherapy and immunotherapy study

Journal of Investigative Dermatology

Kevinn Eddy

Kajal Gupta

Jeffrey C Pelletier

Allison L Isola

Christina Marinaro

...

2023/3/29

Microbial-derived toll-like receptor agonism in cancer treatment and progression

Eileena F Giurini

Mary Beth Madonna

Andrew Zloza

Kajal H Gupta

2022/6/14

A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors

European Journal of Medical Research

Ann W Silk

Biren Saraiya

Roman Groisberg

Nancy Chan

Kristen Spencer

...

2022/7/2

Dual Role of Interferon in Cancer Immunity

Karine Cohen-Solal

Rachael Pulica

Andrew Zloza

Ahmed Lasfar

2022/11/12

Refining colorectal cancer classification and clinical stratification through a single-cell atlas

Genome biology

Ateeq M Khaliq

Cihat Erdogan

Zeyneb Kurt

Sultan Sevgi Turgut

Miles W Grunvald

...

2022/5/11

Overriding impaired FPR chemotaxis signaling in diabetic neutrophil stimulates infection control in murine diabetic wound

Elife

Ruchi Roy

Janet Zayas

Sunil K Singh

Kaylee Delgado

Stephen J Wood

...

2022/2/3

Inactivated sars-cov-2 reprograms the tumor immune microenvironment and improves murine cancer outcomes

bioRxiv

Eileena F Giurini

Michael Williams

Adam Morin

Andrew Zloza

Kajal H Gupta

2022/6/30

Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine Model

Diagnostics

Marco Rossi

Salvatore M Aspromonte

Frederick J Kohlhapp

Jenna H Newman

Alex Lemenze

...

2022/4/12

Bacterial-based cancer therapy (BBCT): recent advances, current challenges, and future prospects for cancer immunotherapy

Vaccines

K.H. Gupta

C. Nowicki

E.F. Giurini

A.L. Marzo

A Zloza

2021/12/18

Dengue virus induces human immune cells to secrete factors capable of tumor cell killing and activation of effector cells against treatment-resistant tumors

The Journal of Immunology

Josef William Goldufsky

Tony Chen

Geeta Singh

Andrew Zloza

Amanda Lee Marzo

...

2021/5/1

See List of Professors in Andrew Zloza, MD, PhD University(Rush University)

Co-Authors

H-index: 53
Anne I. Sperling, PhD

Anne I. Sperling, PhD

University of Chicago

H-index: 38
Jason M Schenkel

Jason M Schenkel

Harvard University

H-index: 28
Jesse Warren Williams

Jesse Warren Williams

University of Minnesota-Twin Cities

H-index: 27
Jai S Rudra

Jai S Rudra

Washington University in St. Louis

H-index: 26
Jared Klarquist

Jared Klarquist

University of Colorado Denver

academic-engine